Hyperglycemia in patients treated with immune checkpoint inhibitors: key clinical challenges and multidisciplinary consensus recommendations
Immune checkpoint inhibitors (ICIs) have an expanding role in the management of numerous cancers. Hyperglycaemia is commonly seen in patients treated with ICIs. However, the differential diagnosis for hyperglycaemia is broad, and incorrect diagnosis can have serious consequences. Herein we review th...
Saved in:
| Main Authors: | Ngai Wah Cheung, Georgina V Long, Roderick Clifton-Bligh, Yiting Huang, Matteo S Carlino, Alexander Maxwell Menzies, Linda Wu, Venessa Tsang, Tim Tse, Meredith Oatley, Jenny Gunton |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-06-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/13/6/e011271.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real-world lenvatinib use in metastatic thyroid cancer: early dose intensity and side effect profile in an Australian centre
by: Monica Majumder, et al.
Published: (2025-06-01) -
MULTIDISCIPLINARY CONSENSUS ON TOPICAL BACTERIAL LYZATE USE
by: article editorial
Published: (2006-04-01) -
Syndrome of increased epithelial permeability in clinical practice. Multidisciplinary national Consensus
by: V. I. Simanenkov, et al.
Published: (2021-02-01) -
Multidisciplinary, multicenter consensus for the care of patients affected with Sturge–Weber syndrome
by: May El Hachem, et al.
Published: (2025-01-01) -
ARIA-Italy multidisciplinary consensus on nasal polyposis and biological treatments: Update 2025
by: Carlo Lombardi, MD, et al.
Published: (2025-05-01)